Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East
Secondary immunodeficiency (SID), acquired hypogammaglobinemia, is an immunodeficiency caused by different factors like diseases, medications, and/or nutrition disorders. Most patients with hematological malignancies (HM), namely chronic lymphocytic leukemia (CLL) and multiple myeloma (MM), experien...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2024-03-01
|
| Edice: | Frontiers in Hematology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/frhem.2024.1347708/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
